Free Trial
NYSEAMERICAN:AZTR

Azitra (AZTR) Stock Price, News & Analysis

$0.60
0.00 (0.00%)
(As of 09/19/2024 ET)

About Azitra Stock (NYSEAMERICAN:AZTR)

Key Stats

Today's Range
$0.57
$0.64
50-Day Range
N/A
52-Week Range
$0.49
$68.40
Volume
403,804 shs
Average Volume
1.04 million shs
Market Capitalization
$4.57 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Azitra, Inc., an early-stage biopharmaceutical company, develops therapies for precision dermatology using engineered proteins and live biotherapeutic products to treat skin diseases. It develops ATR-12, a genetically modified strain of S. epidermidis, which is in Phase Ib clinical trial for treating Netherton syndrome, a skin disease. The company also develops ATR-04, a genetically modified strain of S. epidermidis for treating the papulopustular rash experienced by cancer patients undergoing epidermal growth factor receptor inhibitor; and ATR-01, an engineered recombinant human filaggrin protein for treating ichthyosis vulgaris, a skin disease. It has a collaboration with Bayer. The company was incorporated in 2014 and is based in Branford, Connecticut.

Azitra Stock Analysis - MarketRank™

See Top Rated MarketRank™ Stocks

Overall MarketRank™: 20th Percentile

Azitra scored higher than 20% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Earnings Growth

    Earnings for Azitra are expected to grow in the coming year, from ($3.06) to ($0.95) per share.

  • Price to Book Value per Share Ratio

    Azitra has a P/B Ratio of 0.08. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    2.81% of the float of Azitra has been sold short.
  • Short Interest Ratio / Days to Cover

    Azitra has a short interest ratio ("days to cover") of 0.1, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Azitra has recently decreased by 24.74%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Azitra does not currently pay a dividend.

  • Dividend Growth

    Azitra does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    2.81% of the float of Azitra has been sold short.
  • Short Interest Ratio / Days to Cover

    Azitra has a short interest ratio ("days to cover") of 0.1, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Azitra has recently decreased by 24.74%, indicating that investor sentiment is improving significantly.
  • News Sentiment

    Azitra has a news sentiment score of -0.20. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.44 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 2 news articles for Azitra this week, compared to 0 articles on an average week.
  • Search Interest

    Only 4 people have searched for AZTR on MarketBeat in the last 30 days. This is a decrease of -80% compared to the previous 30 days.
  • MarketBeat Follows

    Only 1 people have added Azitra to their MarketBeat watchlist in the last 30 days. This is a decrease of -80% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Azitra insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 4.90% of the stock of Azitra is held by insiders.

  • Percentage Held by Institutions

    Only 11.16% of the stock of Azitra is held by institutions.

  • Read more about Azitra's insider trading history.
Receive AZTR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Azitra and its competitors with MarketBeat's FREE daily newsletter.

AZTR Stock News Headlines

“I’ll Give You the Knowledge and Confidence You Need to Make Your First Options Trade in Five Days or Less… Guaranteed!”
Starting Monday, September 23 — a veteran 25-year Chicago Options Exchange market-maker will show you his UOA options secret that could help you consistently target gains of 126%… 245%… even 463% or more… Often in 30 days or less… No matter what the market is doing right now.
Azitra Inc (AZTR) Receives a Buy from Maxim Group
AZTR: First ATR-12 Patient Screened
See More Headlines

AZTR Stock Analysis - Frequently Asked Questions

Azitra's stock was trading at $2.7660 at the start of the year. Since then, AZTR stock has decreased by 78.3% and is now trading at $0.5990.
View the best growth stocks for 2024 here
.

Azitra, Inc. (NYSEAMERICAN:AZTR) released its earnings results on Monday, August, 12th. The company reported ($2.74) earnings per share for the quarter, missing the consensus estimate of ($2.59) by $0.15. The company earned $0.01 million during the quarter. Azitra had a negative trailing twelve-month return on equity of 278.76% and a negative net margin of 1,644.90%.

Azitra's stock reverse split on the morning of Monday, July 1st 2024. The 1-30 reverse split was announced on Monday, July 1st 2024. The number of shares owned by shareholders was adjusted after the market closes on Monday, July 1st 2024. An investor that had 100 shares of stock prior to the reverse split would have 3 shares after the split.

Shares of AZTR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Company Calendar

Last Earnings
8/12/2024
Today
9/19/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
NYSEAMERICAN:AZTR
CIK
N/A
Fax
N/A
Employees
10
Year Founded
N/A

Profitability

Net Income
$-11,280,000.00
Net Margins
-1,644.90%
Pretax Margin
-2,435.53%

Debt

Sales & Book Value

Annual Sales
$690,000.00
Book Value
$7.23 per share

Miscellaneous

Free Float
912,000
Market Cap
$4.59 million
Optionable
Not Optionable
Beta
-1.84
10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

This page (NYSEAMERICAN:AZTR) was last updated on 9/19/2024 by MarketBeat.com Staff
From Our Partners